Drugs / Saltra
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06609941 Background | Jun 2024 → Jan 2025 overdue | asthma | Foundation University Islamabad | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Saltra | “Saltra inhaler (Selective long acting β2 adrenoceptor agonist)” NCT06609941 ↗ |
| Action | Activate | “Selective long acting β2 adrenoceptor agonist” NCT06609941 ↗ |
| Route | Inhaled | “Saltra inhaler” NCT06609941 ↗ |